Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201207063 Principal Investigator: Vij, Ravi
Title: A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects with Relapsed or Refractory Multiple Myeloma
Phase: I Disease Site: Multiple Myeloma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
This study is designed to evaluate the effect of ABT-199 in subjects with Multiple Myeloma (MM) who have had their MM come back after treatment with currently available medications and therapies.

The purpose of this study is to determine the safety, pharmacokinetics (how much ABT 199 is absorbed in your body at different times), and the highest safe dose of ABT 199 in subjects with relapsed or refractory MM.
 
More Information:
Internal Protocol Documents (requires Siteman administrative database password)